Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,500 | 6 | 47.3% |
| Food and Beverage | $6,045 | 258 | 27.3% |
| Consulting Fee | $3,600 | 1 | 16.2% |
| Travel and Lodging | $1,986 | 8 | 9.0% |
| Education | $46.89 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $11,336 | 23 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $6,529 | 40 | $0 (2024) |
| Amgen Inc. | $650.82 | 36 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $591.59 | 30 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $553.40 | 29 | $0 (2022) |
| Keryx Biopharmaceuticals, Inc. | $296.26 | 13 | $0 (2018) |
| Lundbeck LLC | $240.24 | 11 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $212.53 | 7 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $187.87 | 9 | $0 (2024) |
| Horizon Therapeutics plc | $154.29 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $384.58 | 20 | Amgen Inc. ($77.48) |
| 2023 | $912.62 | 50 | AstraZeneca Pharmaceuticals LP ($275.52) |
| 2022 | $371.31 | 21 | Otsuka America Pharmaceutical, Inc. ($89.00) |
| 2021 | $440.21 | 11 | Fresenius USA Marketing, Inc. ($273.17) |
| 2020 | $235.02 | 13 | Amgen Inc. ($65.85) |
| 2019 | $6,929 | 61 | AstraZeneca Pharmaceuticals LP ($6,165) |
| 2018 | $2,623 | 55 | Relypsa, Inc. ($1,641) |
| 2017 | $10,283 | 48 | Relypsa, Inc. ($9,678) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Genetic Disease | ||||||
| 04/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 03/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Cardiology | ||||||
| 03/25/2024 | Amgen Inc. | Aranesp (Biological), Parsabiv | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Nephrology | ||||||
| 03/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/08/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Inflammation/Rare Disease | ||||||
| 03/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Inflammation | ||||||
| 03/05/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 02/26/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Cardiology | ||||||
| 02/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardio-renal | ||||||
| 02/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: NEPHROLOGY | ||||||
| 02/06/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 02/01/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Cardio-renal | ||||||
| 01/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.65 | General |
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/11/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.85 | General |
| 01/09/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 12/22/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: NEPHROLOGY | ||||||
| 12/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: KRYSTEXXA | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/08/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Nephrology | ||||||
| 12/06/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 3,632 | 9,127 | $1.1M | $290,671 |
| 2022 | 39 | 3,425 | 7,504 | $1.1M | $303,614 |
| 2021 | 41 | 2,433 | 5,485 | $1.1M | $320,208 |
| 2020 | 32 | 1,604 | 4,970 | $629,224 | $283,698 |
All Medicare Procedures & Services
148 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 45 | 321 | $350,471 | $87,620 | 25.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 162 | 517 | $167,368 | $48,377 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 591 | $201,643 | $44,749 | 22.2% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 95 | 2,965 | $74,125 | $17,400 | 23.5% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 95 | 219 | $50,109 | $12,343 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 88 | 97 | $41,319 | $10,033 | 24.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $40,496 | $8,810 | 21.8% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 136 | 199 | $24,644 | $8,013 | 32.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 17 | 28 | $25,732 | $6,586 | 25.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 135 | 201 | $17,849 | $5,805 | 32.5% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 47 | 47 | $17,096 | $3,815 | 22.3% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 18 | 18 | $14,794 | $3,154 | 21.3% |
| 82746 | Folic acid level, serum | Office | 2023 | 125 | 203 | $8,952 | $2,912 | 32.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 144 | 345 | $5,697 | $2,890 | 50.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 124 | 192 | $8,686 | $2,825 | 32.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 127 | 207 | $8,464 | $2,753 | 32.5% |
| 82610 | Cystatin c (enzyme inhibitor) level | Office | 2023 | 101 | 134 | $7,445 | $2,432 | 32.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 141 | 213 | $9,159 | $2,195 | 24.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 142 | 227 | $7,264 | $1,721 | 23.7% |
| 83550 | Iron binding capacity | Office | 2023 | 124 | 197 | $5,165 | $1,678 | 32.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 92 | 119 | $4,780 | $1,561 | 32.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 97 | 131 | $6,657 | $1,505 | 22.6% |
| 83735 | Magnesium level | Office | 2023 | 141 | 211 | $4,241 | $1,380 | 32.5% |
| 85046 | Red blood count automated, with additional calculations | Office | 2023 | 143 | 243 | $5,589 | $1,322 | 23.7% |
| 83540 | Iron level | Office | 2023 | 124 | 197 | $3,824 | $1,243 | 32.5% |
About Dr. Pankaj Ram, MD
Dr. Pankaj Ram, MD is a Nephrology healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679539837.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pankaj Ram, MD has received a total of $22,178 in payments from pharmaceutical and medical device companies, with $384.58 received in 2024. These payments were reported across 279 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,500).
As a Medicare-enrolled provider, Ram has provided services to 11,094 Medicare beneficiaries, totaling 27,086 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 148 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Fresno, CA
- Active Since 04/25/2006
- Last Updated 02/15/2008
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679539837
Products in Payments
- Veltassa (Drug) $11,352
- LOKELMA (Drug) $6,313
- Velphoro (Drug) $553.40
- JYNARQUE (Drug) $495.53
- Parsabiv (Biological) $307.48
- Auryxia (Drug) $296.26
- NORTHERA (Drug) $240.24
- ACTHAR (Biological) $234.14
- Kerendia (Drug) $199.47
- FARXIGA (Drug) $195.44
- KRYSTEXXA (Biological) $189.14
- Parsabiv (Drug) $143.82
- INJECTAFER (Drug) $129.72
- Renal - PD (Device) $124.74
- Aranesp (Biological) $121.47
- SOLIRIS (Drug) $97.79
- SAMSCA (Drug) $96.06
- TARPEYO (Drug) $89.55
- OCTAPLAS (Biological) $58.03
- BENLYSTA (Biological) $51.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Fresno
Steven Levy, Md, MD
Nephrology — Payments: $8,030
Ms. Adela Ayala, Rn, Np, RN, NP
Nephrology — Payments: $8,005
Hemant Dhingra
Nephrology — Payments: $7,906
Mr. Nishkarsh Saxena, Md, MD
Nephrology — Payments: $5,294
Glenn Garbutt, M.d, M.D
Nephrology — Payments: $4,504
Joseph Duflot, Md, MD
Nephrology — Payments: $4,490